Autism-Related Dietary Preferences Mediate Autism-Gut Microbiome Associations

Published:November 11, 2021DOI:https://doi.org/10.1016/j.cell.2021.10.015 Highlights Summary There is increasing interest in the potential contribution of the gut microbiome to autism spectrum disorder (ASD). However, previous studies have been underpowered and have not been designed to address potential confounding factors in a comprehensive way. We performed a large autism stool metagenomics study (n = 247) based on participants…

Read More

Could the Gut Microbiome be Linked to Autism?

Researchers are hoping to understand whether the microbes in our guts have a role in the disorder. Before Ethan Loyola reached his first birthday, it was clear that something was wrong with his gut. As a baby, he had been given several courses of antibiotics to treat severe ear infections, after which he experienced foul-smelling,…

Read More

A Biospecimen Crisis in Biotech?

All crises are not equal, but they all need to be recognised, says Robert Hewitt Robert Hewitt is the founder of Biosample Hub, a new platform that connects biotech companies looking for samples with biobanks that have ethically sourced samples available A dictionary definition of a crisis is a time of great difficulty or danger…

Read More

Memorandum of Understanding Signed by NCI, FDA and HRSA to Bring Cancer Diagnostic Devices Closer to Patients, Particularly Members of Medically Underserved and Geographically Isolated Communities

On Friday, September 17, 2021, leadership from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Health Resources and Services Administration (HRSA) signed a Memorandum of Understanding (MOU) to support solutions for early cancer detection and diagnosis to improve patient outcomes, quality of life, and reduce health disparities among medically underserved, geographically isolated,…

Read More

Withdrawal of FDA EUA for CDC 2019-Novel Coronavirus RT-PCR Diagnostic Panel

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have…

Read More

Parexel Snapped Up, Again, as Goldman Sachs, EQT Spend $8.5B on the CRO

The rumors were true: Whispers grew this year that Parexel, owned for the past four years by Pamplona Capital, was seeking a sale or an IPO. Today, the whispers stopped as the CRO loudly declared it is being bought out for $8.5 billion. The suitors and soon-to-be owners are the Swedish investment firm EQT Private Equity and the…

Read More

China Embraces Decentralized Clinical Trial Solutions

Surveys show patients, sponsors and CROs in Chinasee the benefits of virtual and hybrid trials. Concernsremain around regulatory gaps, digital data collectionand study logistics. View White PaperBy MAGGIE MA, Director of Clinical Operations – IQVIA, China

Read More

FDA Authorizes New Device to Help Diagnose Pediatric Autism

Posted 02 June 2021 | By Joanne S. Eglovitch  The US Food and Drug Administration on 2 June authorized the marketing of a first-of-its kind device intended to help diagnose autism spectrum disorder (ASD) in children aged 18 months through 5 years. The device was developed by Cognoa, a company based in Palo Alto, CA, that…

Read More